CVS Health’s (CVS) retail division — CVS Pharmacy — launched Well Market,  a new store brand consumables line featuring snacks, beverages and groceries. Products from Well Market can now be purchased on CVS.com and in CVS pharmacies across the United States.The recent development will expand CVS Health’s food and beverage portfolio.More on Well MarketWell Market provides a range of products with zero grams of trans fat and no artificial preservatives, sweeteners, or colors and products that reflect consumer ...

WOONSOCKET, R.I., May 20, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that President and CEO Karen S. Lynch and Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Bernstein 40th Annual Strategic Decisions Conference on May 29, 2024, at approximately 10:00 am ET.An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it wil ...

Key PointsCVS Health operates over 9,000 pharmacies as well as the nation’s third-largest health insurer, Aetna.CVS Health stock has a 4.64% annual dividend yield and trades at just 8.19X forward earnings compared to the 10-year average PE of 18.19, a 65% discount.Aetna suffered over $900 million in unexpected Medicare Advantage (MA) utilization expenses in Q1. Still, it stated that it will prioritize profits in 2025, cut certain supplemental benefits, and exit counties it deems unprofitable for MA.5 stocks ...

NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether CVS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2024, CVS issued a pr ...

CVS Pharmacy, the retail division of CVS Health, launched a new store brand for snacks, beverages and groceries.The new Well Market brand features nutrition options, bold flavors, recyclable packaging and selections that meet specific dietary needs, the company said in a Thursday (May 16) press release.Forty products were made available on store shelves and CVS.com Thursday, and more will be rolled out through the end of the year, according to the release.“Through this repositioning and expansion of our foo ...

WOONSOCKET, R.I., May 16, 2024 /PRNewswire/ -- CVS Pharmacy® (NYSE: CVS), the retail division of CVS Health®, today announced the launch of Well Market™, a new store brand consumables line featuring snacks, beverages and groceries.Well Market, CVS Pharmacy's new store brand consumables line featuring snacks, beverages and groceries, offers a fusion of nutrition options and irresistible flavors that cater to diverse taste preferences."Our goal at CVS Health is to be the most consumer-centric health care solu ...

Juanmonino/iStock Unreleased via Getty Images Investment Thesis I'm not sure how many investors currently hold CVS Health Corporation (NYSE:CVS) for the growth or the dividend, but with the recent drop in share price, some may be left wondering if the dividend is secure. As an investor solely investing for dividends to supplement my retirement, this is always my main concern when my portfolio holdings have a bad quarter or year. In this article, I discuss the company's recent earnings, which caused the stoc ...

Is this still a safe dividend stock you can buy and hold for the long haul?Shares of CVS Health (CVS -0.83%) have been under pressure this month after the healthcare giant reported uninspiring quarterly results. It also reduced its guidance for the year. With the company facing higher costs and headwinds due to macroeconomic conditions, investors have grown wary of the stock, and its dividend as well. Now yielding around 4.8% per year, is CVS Health's dividend too high and due for a cut?Can CVS Health affor ...

CVS Health Corporation Conference Call Summary Company Overview - **Company**: CVS Health Corporation (NYSE: CVS) - **Event**: BofA Securities 2024 Health Care Conference - **Date**: May 14, 2024 - **Participants**: CFO Thomas Cowhey, Head of IR Larry McGrath, Analyst Allen Lutz Key Points Financial Performance - **First Quarter Results**: Company expressed disappointment with first quarter results, indicating performance was not acceptable and acknowledging the need for improvement in Medicare Advantage [2][3] - **Medicare Advantage**: Company believes it can be a significant business but will take a couple of years to get back on track, starting with 2025 bids [2][3] - **Healthcare Benefits Miss**: Missed healthcare benefits by approximately $900 million due to higher-than-anticipated medical costs, with $400 million attributed to increased utilization in outpatient services and behavioral health [5][6] Business Segments - **Pharmacy and Consumer Wellness**: Strong growth in pharmacy and consumer wellness business, with scripts growing well above market levels [3] - **Health Services Segment**: Experienced timing issues in the first quarter, but the Cordavis and Caremark businesses are expected to recapture lost dollars [19][24] - **Oak Street**: Achieved one of the best years since the pandemic, with consistent performance in line with expectations [20] Future Guidance - **Earnings Guidance**: Projected earnings of $7 per share, with 55% to 60% expected in the back half of the year [15][16] - **Margin Improvement**: Aiming for a margin of 4% to 5% by adjusting benefits and enhancing medical management [9][11] - **Cash Flow**: Projected cash flow from operations over $10.5 billion for the year, with a balanced approach to capital deployment [27] Strategic Initiatives - **CostVantage and TrueCost**: New reimbursement models aimed at improving transparency and addressing reimbursement pressures faced by retail pharmacies [33][34] - **Cordavis Success**: Transition to biosimilars has been successful, with significant savings for clients and high conversion rates [30][31][32] - **Regulatory Compliance**: Company is fully compliant with recent legislation focusing on transparency in the PBM business [39] Challenges and Risks - **Utilization Forecasting**: Difficulty in forecasting utilization trends for 2023 and 2024, with potential impacts from the Inflation Reduction Act [9][40][42] - **Medicare Membership**: Potential loss of up to 10% of existing Medicare members as the company prioritizes margin over membership [14] Legislative Impact - **Inflation Reduction Act**: Anticipated changes to Part D could lead to increased prices and shifted risk to plans, impacting pricing strategies for 2025 [40][42] Additional Insights - **Market Dynamics**: The company is actively engaging with stakeholders to adapt to changing market conditions and regulatory environments [38][39] - **Long-term Strategy**: CVS is focused on sustainable growth through innovative products and strategic partnerships while managing risks associated with healthcare trends and regulations [11][12][32]

Year to date, shares of CVS are now down by nearly 30%.Shares of CVS Health (CVS 0.25%) have been falling sharply this month after investors were unimpressed with the healthcare giant's latest earnings numbers. The sell-off has been so extreme that not only is CVS trading near its 52-week low, but the stock is now at levels it hasn't been at since 2020. It seems to be trading at a high discount, and with the big decline in price, its dividend is now yielding 4.8%, which is far higher than normal.Is the sell ...